GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 19051 - 19100 of 39437 in total
PDB ID UniProt ID Title ▲ Descriptor
3G72 P00797 Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors Renin (E.C.3.4.23.15)
3O9L P00797 Design and optimisation of new piperidines as renin inhibitors Renin (E.C.3.4.23.15), Renin (E.C.3.4.23.15)
3OAD P00797 Design and optimization of new piperidines as renin inhibitors Renin (E.C.3.4.23.15)
3OAG P00797 Design and optimization of new piperidines as renin inhibitors Renin (E.C.3.4.23.15)
1NA0 1NA0 Design of Stable alpha-Helical Arrays from an Idealized TPR Motif
1NA3 1NA3 Design of Stable alpha-Helical Arrays from an Idealized TPR Motif
1NO9 P00734 Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
1NO9 P28501 Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
1Y4C P02928 Designed Helical Protein fusion MBP
6NE1 Q9ULV1 Designed repeat protein in complex with Fz4
6NE1 6NE1 Designed repeat protein in complex with Fz4
6NE2 O75084 Designed repeat protein in complex with Fz7
6NE2 6NE2 Designed repeat protein in complex with Fz7
2ALU P24627 Detection of new binding site in the C-terminal lobe of lactoferrin:Crystal structure of the complex formed between bovine lactoferrin and a tetrasaccharide at 2.1A resolution Lactotransferrin
7UWP L8GJB3 Detergent-bound CYP51 from Acanthamoeba castellanii
5A6M A3DJS9 Determining the specificities of the catalytic site from the very high resolution structure of the thermostable glucuronoxylan endo-Beta-1, 4-xylanase, CtXyn30A, from Clostridium thermocellum with a xylotetraose bound
1OGO P48845 Dex49A from Penicillium minioluteum complex with isomaltose DEXTRANASE (E.C.3.2.1.11)
2LHX 2LHX Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat
2LHY 2LHY Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat
2LHZ 2LHZ Di-O-GalNAc glycosylated Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat
5MTX Q16539 Dibenzooxepinone inhibitor 12b in complex with p38 MAPK
5MTY Q16539 Dibenzosuberone inhibitor 8e in complex with p38 MAPK
4ZZQ Q55FE6 Dictyostelium discoideum cellobiohydrolase Cel7A apo structure
4ZZP F0ZJZ1 Dictyostelium purpureum cellobiohydrolase Cel7A apo structure
1XLW P06276 Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate
3QYT P02787 Diferric bound human serum transferrin
1N04 P02789 Diferric chicken serum transferrin at 2.8 A resolution.
4AZ7 P49610 Differential inhibition of the tandem GH20 catalytic modules in the pneumococcal exo-beta-D-N-acetylglucosaminidase, StrH
4AZH P49610 Differential inhibition of the tandem GH20 catalytic modules in the pneumococcal exo-beta-D-N-acetylglucosaminidase, StrH
4TW9 P48730 Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation
7V1W A0A6L9SN29 Difructose dianhydride I synthase/hydrolase (alphaFFase1) from Bifidobacterium dentium in complex with beta-D-arabinofuranose
7V1X A0A6L9SN29 Difructose dianhydride I synthase/hydrolase (alphaFFase1) from Bifidobacterium dentium in complex with beta-D-fructofuranose
6MM9 P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MM9 Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024